Journals / Eurasian Journal of Medicine / 2020 / Cilt: 52 - Sayı: 3

Behçet's Disease: Different Systemic Manifestations at Different Ages

Pages
304–306
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As in the case presented here, Behçet’s disease can manifest with the central nervous system involvement early in life and pulmonary involvement in adulthood.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Behçet’s disease, an inflammatory condition, can involve various systems.
📊
Key Findings & Data:The disease usually manifests with dermatologic and ocular signs but can also cause serious symptoms due to pulmonary or neurologic involvement.
💡
Conclusion & Impact:As in the case presented here, Behçet’s disease can manifest with the central nervous system involvement early in life and pulmonary involvement in adulthood.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Behçet’s disease, an inflammatory condition, can involve various systems. The disease usually manifests with dermatologic and ocular signs but can also cause serious symptoms due to pulmonary or neurologic involvement. Although the onset may occur at any age, it typically emerges in the second to fourth decades of life. As in the case presented here, Behçet’s disease can manifest with the central nervous system involvement early in life and pulmonary involvement in adulthood.

🔖

Cite This Article

ARAZ, Ö., UÇAR, E. Y., AKGÜN, M., KARAMAN, A., SAĞLAM, L. (2022). Behçet's Disease: Different Systemic Manifestations at Different Ages. Eurasian Journal of Medicine, Cilt: 52 - Sayı: 3, 304–306. https://ajindex.com/articles/508903

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kaklamani VG, Variopoulos G, Kaklamanis PG. Behçet's disease. Semin Arthritis Rheum 1998; 27: 197-217. [Crossref] 2. Zouboulis CC, Kötter I, Djawari D, et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-22. [Crossref] 3. Nussenblatt RB. Uveitis in Behçet's disease. Int Rev Immunol 1997; 14: 67-79. [Crossref] 4. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982; 100: 1455-8. [Crossref] 5. Sakane T. New perspective on Behçet's disease. Int Rev Immunol 1997; 14: 89-96. [Crossref] 6. Alpsoy E. Behçet's disease: treatment of mucocutaneous lesions: Clin Exp Rheumatol 2005; 23: 532-9. 7. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behcet's disease: an analysis of 2147 patients. Yonsei Med J 1997; 38: 423-7. [Crossref] 8. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76. [Crossref] 9. Lewis MA, Priestley BL. Transient Behcets disease. Arch Dis Child 1986; 61: 805-6. [Crossref] 10. Guzelin G, Norton ME. Behcet syndrome associated with intrauterine growth restriction: a case report and review of the literature. J Perinatol 1997; 17: 318-20. 11. Rakover Y, Adar H, Tal I, et al. Behcet disease: long-term follow-up of three children and review of the literature. Pediatrics 1989; 83: 986-92. 12. Jog S, Patole S, Koh G, et al. Unusual presentation of neonatal Behcet's disease. Am J Perinatol 2001; 18: 287-92. [Crossref] 13. Al-Fahad AS, Al-Araji AH. Neuro-Behçet's disease in Iraq: a study of 40 patients. J Neurol Sci 1999; 170: 105-11. [Crossref] 14. Tunacı A, Berkmen YM, Gökmen E. Thoracic involvement in Behçet's disease: pathologic, clinical, and imaging features. Am J Roentgenol 1995; 164: 51-6. [Crossref] 15. Duchêne F, Berthier S, de Wazières B, et al. Behcet's disease with cardiac and pulmonary manifestations. Presse Med 1998; 27: 1674-6.